This is a research network for the UKPGx Network, whose main aim is to develop collaborations between academics, clinicians and industry partners, with the purpose of catalysing research opportunities within the fast growing field of stratified medicine. By organising conferences, symposia and focused workshops the Network will provide unique opportunities to foster multidisciplinary partnerships, and help develop a stratified medicine approach to improve drug delivery to patients. Our website provides up-to date information for all those working in this growing field and represents a one-stop resource to identify other academic researchers/industry partners that could be useful in developing multidiscipline collaborations.
External link for UK Pharmacogenetics and Stratified Medicine Network (UKPGx)
The Wolfson Centre for Personalised Medicine
1-5 Brownlow Street
Liverpool, Merseyside L69 3GL, GB
UK Pharmacogenetics and Stratified Medicine Network (UKPGx) reposted this
Some might say that you could save up to 50% on #Pharmacology2024 tickets when you book by 29 October 2024. 👀 Don't look back in anger - secure yours today: https://ow.ly/ojUQ50T7ekE 😛 #Oasis #OasisReunion #Oasis2025 #Pharmacology
UK Pharmacogenetics and Stratified Medicine Network (UKPGx) reposted this
Best of luck to everyone receiving their #ScottishHighers results today! 🍀 If you have a passion for science and want to make a difference in medicine and health, a career in pharmacology could be for you! There's is a wide range of roles available with or without a university degree. Training as a pharmacologist also equips you with a wide range of transferable skills for many different career paths. Visit our careers pages for more info on degrees and career options: https://lnkd.in/e8Z_PCsb #ScottishHighersResults #ResultsDay #UCAS #Pharmacology #ClinicalPharmacology #PharmacologyCareers #ScienceCareers #STEMCareers #BioScience #Biology #Highers #HigherEducation #Degrees #Clearing
UK Pharmacogenetics and Stratified Medicine Network (UKPGx) reposted this
After winning an award from Innovate UK, the BPS and the University of Liverpool have been running a series of workshops on implementing #pharmacogenomics in clinical practice in the NHS. Pharmacogenomics is a key thematic priority for the BPS, so this award is an important step in helping us realise our goal of bringing personalised medicine to as many people as possible. The award from Innovate UK, which is part of UK Research and Innovation, will enable the team to organise a regulatory network and to develop guidance and tools to identify the regulatory hurdles that may be holding back pharmacogenomics from being fully embedded into the NHS. https://ow.ly/5Mjy50SP30X
UK Pharmacogenetics and Stratified Medicine Network (UKPGx) reposted this
🗣️ Share your views and experiences of engaging with the UK Government. The Government Office for Science wants to hear from the academic community, particularly academic researchers! 🔬💊🧬 #AcademicResearch #AcademicResearchers #Pharmacology #ScienceAcademia
📢 Calling all academics! We would love to hear you views on interacting with the Government, including the types of engagement you have had and the factors impacting this. Have your say by filling out this survey: https://lnkd.in/eu4jsXSi. Deadline: 5pm on 16.08.
🧬💊 Last week we held our 11th Annual Open Meeting of the UK Pharmacogenetics & Stratified Medicine Network (#UKPGx2024). 🎉 It was fantastic to have some many inspiring and passionate people under one roof. We had fantastic talks from the Chief Scientific Officer of the NHS, academic researchers, industry leaders, clinicans and policy makers. Thank you everyone for joining us! We will release recordings of the talks very soon. ✨ For now, please make sure to: 🧬 Join the UKPGx Network for free: https://lnkd.in/eycMw62c 💊 Become a member of the British Pharmacological Society: https://lnkd.in/erDdYJ8p 🎟️ Register for #Pharmacology2024 this December, which features a couple of sessions on pharmacogenomics: https://lnkd.in/g7ugnWyY Thanks to: Prof Sir Munir Pirmohamed, Dr John H McDermott, Prof Aroon Hingorani, Prof Michael Johnson, Prof Julian Knight, Dr Julia Carrasco Zanini Sanchez, Dr Emma Magavern, Prof Dame Sue Hill, Prof Nick Wareham, Prof Raghib Ali OBE, , Dr Verena Zuber, Dr Greet De Baets, Vicky Chaplin, Professor Ann Daly,D and Dr Karen Spink Thanks to event partners: Eurofins Genomics, Agena Bioscience, FDB (First Databank, Inc.), genedrive, GenQA (Genomics Quality Assessment), Inagene Diagnostics UK, LaCAR MDX Technologies, and Mantara Health. Thanks to Royal College of Physicians for hosting us! #Pharmacogenomics #Pharmacogenomics #UKPGx #PGx #StratifiedMedicine #PersonalisedMedicine #PrecisionMedicine #PGxTest #PGxTestint #Genomics #Genetics #NHS #Pharmacology #ClinicalPharmacology Edited · 26 m
A very interesting post about the language of #pharmacogenomics by John H McDermott who spoke at our Annual Open Meeting last week! #UKPGx2024 #UKPGx #Pharmacogenetics #StratifiedMedicine
💬 We need to talk about language and pharmacogenomics! For once, I'm not thinking about testing technologies or data standards, but how we generally discuss pharmacogenomics as a healthcare intervention. 📈 The last few years has seen a rapidly increasing interest in pharmacogenomics. In general, this is great, and there are some phenomenal implementation efforts taking place around the world. 🧬 One of the reasons that pharmacogenomics has captured so much attention is because it can be so easy to explain. ✨ “Your genetics can be used to select the best medicines for you” ✨ Simplicity is important and useful, but there is a fine line between simplicity and inaccuracy. 🛑 In striving for a simple message there are 4️⃣ main inaccuracies which tend to reoccur: 1️⃣ Treating risk as binary. Pharmacogenomic variants can increase the risk of an adverse drug reaction or reduced effectiveness. That risk varies depending on the clinical scenario, the specific gene-drug pair, and what your baseline risk was to begin with. Critically, carrying one of these variants does not mean you will absolutely go on to have an adverse reaction or poor response. Too often, pharmacogenomics is presented through a binary and deterministic lens. 2️⃣ Failure to contextualise. Pharmacogenomic results are just one part of a patient’s overall clinical picture. A patient’s medical history, other medicines, and environmental exposures can also impact medicines. Ignoring these factors and using pharmacogenomics in isolation is inappropriate. 3️⃣ Treating all gene-drug pairs equally. Across the pharmacogenomic literature, there are some gene-drug pairs with extremely strong evidence, and others with very little. Messaging which fails to communicate that misrepresents the reality. 4️⃣ The implementation gap. The (relatively) easy bit of pharmacogenomics is the genetic testing and producing a PDF report. The hard bit is ensuring that results are A) available over time ⏱ and B) accessible for reuse 🔄. Testing without a strategy for how clinicians and patients can access and reuse results has limited usefulness. In specific clinical scenarios, when properly contextualised and implemented, pharmacogenomics is clearly a huge health opportunity. However, it is now too often spoken about, without qualification, as a singularly powerful intervention, akin to a “silver bullet”, which will improve all prescribing practice and reduce burden across healthcare systems. 🙅♂️ Such exaggeration isn’t right and shouldn’t be the message communicated to patients or members of the public. 🆕 Over the coming months, we will look to share simple, considered and research-based based information that helps raise the right awareness on the exciting potential for pharmacogenomics to improve patients care.
UK Pharmacogenetics and Stratified Medicine Network (UKPGx) reposted this
Thanks to everyone for joining us at #UKPGx2024 today! If you're not a member yet, you can join for free: https://lnkd.in/grZJ2-5H We also encourage you to attend the British Pharmacological Society's #Pharmacology2024 event this December. There will be a couple of sessions on pharmacogenetics: https://lnkd.in/g2BNFJQa See you soon! #UKPGx #Pharmacogenetics #Pharmacogenomics #PGx #StratifiedMedicine
UK Pharmacogenetics and Stratified Medicine Network (UKPGx) reposted this
Closing #UKPGx2024 we had Dr Greet De Baets from AstraZeneca, and Professor Julian Knight from University of Oxford for their talks on new technology platforms for pharmacogenomics. Thanks to Dr Karen Spink from Innovate UK for chairing #Pharmacogenetics #Pharmacogenomics #PGx #UKPGx #StratifiedMedicine #PrecisionMedicine #AI #NHS
Thanks to everyone for joining us at #UKPGx2024 today! If you're not a member yet, you can join for free: https://lnkd.in/grZJ2-5H We also encourage you to attend the British Pharmacological Society's #Pharmacology2024 event this December. There will be a couple of sessions on pharmacogenetics: https://lnkd.in/g2BNFJQa See you soon! #UKPGx #Pharmacogenetics #Pharmacogenomics #PGx #StratifiedMedicine
Closing #UKPGx2024 we had Dr Greet De Baets from AstraZeneca, and Professor Julian Knight from University of Oxford for their talks on new technology platforms for pharmacogenomics. Thanks to Dr Karen Spink from Innovate UK for chairing #Pharmacogenetics #Pharmacogenomics #PGx #UKPGx #StratifiedMedicine #PrecisionMedicine #AI #NHS